This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignee: Novartis Ag. Active years: 2024-2025.
Company Filing History:
Years Active: 2024-2025
Title: Irina Baltcheva: Innovator in Factor B Inhibitors
Introduction
Irina Baltcheva is a prominent inventor based in Oberwil, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of paroxysmal nocturnal hemoglobinuria (PNH). With a total of 2 patents to her name, her work is paving the way for innovative therapies.
Latest Patents
Irina's latest patents focus on methods of using factor B inhibitors. These patents describe methods for treating PNH with the Factor B inhibitor LNP023 or a pharmaceutically acceptable salt thereof, such as LNP023 hydrochloride. Her research is crucial in developing effective treatments for patients suffering from this rare blood disorder.
Career Highlights
Irina is currently employed at Novartis AG, a leading global healthcare company. Her role involves extensive research and development in the field of pharmaceuticals, where she applies her expertise to create innovative solutions for complex medical challenges.
Collaborations
Irina collaborates with notable colleagues, including Peter End and Julie Marie-Pomme Gabrielle Milojevic. These partnerships enhance her research efforts and contribute to the advancement of her projects.
Conclusion
Irina Baltcheva's work in the field of factor B inhibitors exemplifies her dedication to improving patient outcomes through innovative treatments. Her contributions are vital to the ongoing development of therapies for PNH, showcasing the impact of her research on the medical community.